Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Leslie's (LESL) Asset Writedowns and Impairment (2019 - 2025)

Historic Asset Writedowns and Impairment for Leslie's (LESL) over the last 7 years, with Q1 2025 value amounting to -$79000.0.

  • Leslie's' Asset Writedowns and Impairment fell 14438.2% to -$79000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.4 million, marking a year-over-year increase of 24871.13%. This contributed to the annual value of $1.5 million for FY2024, which is 65958.55% up from last year.
  • Latest data reveals that Leslie's reported Asset Writedowns and Impairment of -$79000.0 as of Q1 2025, which was down 14438.2% from $284000.0 recorded in Q4 2024.
  • In the past 5 years, Leslie's' Asset Writedowns and Impairment ranged from a high of $2.0 million in Q4 2021 and a low of -$98000.0 during Q3 2023
  • In the last 5 years, Leslie's' Asset Writedowns and Impairment had a median value of $168500.0 in 2022 and averaged $286388.9.
  • Per our database at Business Quant, Leslie's' Asset Writedowns and Impairment surged by 328000.0% in 2022 and then crashed by 14438.2% in 2025.
  • Over the past 5 years, Leslie's' Asset Writedowns and Impairment (Quarter) stood at $2.0 million in 2021, then tumbled by 99.49% to $10000.0 in 2022, then skyrocketed by 1300.0% to $140000.0 in 2023, then soared by 102.86% to $284000.0 in 2024, then tumbled by 127.82% to -$79000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$79000.0 in Q1 2025, compared to $284000.0 in Q4 2024 and $459000.0 in Q3 2024.